Aardvark TherapeuticsAARD
那斯達克 · USD
6.23
-0.52
(-7.70%)
盤中 08/20 10:43 (UTC+8)
08/20 10:43 (UTC+8)
Aardvark TherapeuticsAARD
6.23
-0.52
(-7.70%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 15,084 | 22,464 | 18,704 | 17,703 | 15,848 | - | 9,450 | 5,091 | 6,059 | 2,171 |
研發費用 | 10,455 | 16,567 | 14,299 | 13,737 | 13,145 | 7,755 | 8,062 | 4,065 | 4,029 | 1,207 |
推銷及管理費用 | 4,629 | 5,897 | 4,405 | 3,966 | 2,703 | 2,715 | 1,388 | 1,026 | 2,030 | 861 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -15,084 | -22,464 | -18,704 | -17,703 | -15,848 | -10,470 | -9,450 | -5,091 | -6,059 | -2,171 |
其他收入及費用 | 697 | 876 | 1,106 | 1,387 | 1,481 | 1,160 | 671 | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -14,387 | -21,588 | -17,598 | -16,316 | -14,367 | -9,310 | -8,779 | -4,182 | -5,449 | -2,178 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -14,387 | -21,588 | -17,598 | -16,316 | -14,367 | -9,310 | -8,779 | -4,182 | -5,449 | -2,178 |
基本每股稅後盈餘(元) | -0.66 | -0.99 | -0.81 | -0.75 | -0.66 | -0.71 | - | -0.20 | -0.25 | -0.17 |
稀釋每股稅後盈餘(元) | -0.66 | -0.99 | -0.81 | -0.76 | -0.65 | -0.71 | -2.18 | -0.20 | -0.25 | -0.17 |
基本平均股數(千股) | 21846.00 | 21815.00 | 21782.00 | 21713.00 | 21690.00 | 13194.00 | - | 21384.00 | 21384.00 | 12909.00 |
稀釋平均股數(千股) | 21846.00 | 21815.00 | 21782.00 | 21713.00 | 21690.00 | 13194.00 | - | 21384.00 | 21384.00 | 12909.00 |
還原基本每股稅後盈餘(元) | -0.66 | -0.99 | -0.81 | -0.75 | -0.66 | -0.71 | - | -0.20 | -0.25 | -0.17 |
還原稀釋每股稅後盈餘(元) | -0.66 | -0.99 | -0.81 | -0.76 | -0.65 | -0.71 | -2.18 | -0.20 | -0.25 | -0.17 |
還原基本平均股數(千股) | 21,846 | 21,815 | 21,782 | 21,713 | 21,690 | 13,194 | - | 21,384 | 21,384 | 12,909 |
還原稀釋平均股數(千股) | 21,846 | 21,815 | 21,782 | 21,713 | 21,690 | 13,194 | - | 21,384 | 21,384 | 12,909 |
EBITDA(千元) | -14,395 | -21,695 | -17,821 | -16,678 | -14,976 | -9,386 | -8,867 | -4,174 | -5,451 | -2,176 |